UNCEMENTED ARTHROPLASTY AFTER HIP METASTATIC DISEASE AND MULTIPLE MYELOMA

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
ATHA COMUNICACAO & EDITORA
Citação
ACTA ORTOPEDICA BRASILEIRA, v.24, n.4, p.191-195, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To describe a case series using a combination of narrative, graphical exploratory analysis and Bayesian Network modeling. Methods: Case series with 34 patients undergoing uncemented and hybrid arthroplasty procedures secondary to hip pain or fracture secondary to metastatic disease or multiple myeloma. Results: The most common tumors included gastrointestinal, multiple myeloma and breast cancer. Most devices were total arthroplasty (n = 16, 84.2%) rather than partial and uncemented arthroplasty (n = 12, 63.2%) rather than hybrid. The average time between surgery and deambulation was 20 days, the average length of hospital stay was 13 days, and the average patient survival was 589 days. Only one infection was reported. Uncemented and hybrid arthroplasty devices did not differ regarding time to walk, as well as the length of hospital stay in this sample. Conclusion: Our model may be used as a prior for the addition of subsequent patient samples, personalizing, thus, its recommendations to other patient populations.
Palavras-chave
Arthroplasty, replacement, hip, Neoplasm metastasis, Bone neoplasms
Referências
  1. Chow E, 2007, J CLIN ONCOL, V25, P1423, DOI 10.1200/JCO.2006.09.5281
  2. Clement-Demange L, 2015, CURR OPIN PHARMACOL, V22, P79, DOI 10.1016/j.coph.2015.04.004
  3. Felden A, 2015, BONE JOINT J, V97B, P177, DOI 10.1302/0301-620X.97B2.34545
  4. Fenton N., 2012, RISK ASSESSMENT DECI
  5. Friedman N, 1999, P 15 C UNC ART INT U, P206
  6. Gartrell BA, 2014, NAT REV CLIN ONCOL, V11, P335, DOI 10.1038/nrclinonc.2014.70
  7. [郭卫 GUO Wei], 2009, [中华外科杂志, Chinese Journal of Surgery], V47, P1718
  8. HERTLEIN H, 1993, ZBL CHIR, V118, P532
  9. Kempen JH, 2011, AM J OPHTHALMOL, V151, P7, DOI 10.1016/j.ajo.2010.08.047
  10. Kiatisevi P, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/1477-7819-13-4
  11. Kynaston-Pearson F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6956
  12. [李守民 Li Shou-min], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P8381
  13. Min L, 2014, INDIAN J ORTHOP, V48, P289, DOI 10.4103/0019-5413.132521
  14. Nieuwenhuijse MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5133
  15. Post ZD, 2013, J COMP EFFECT RES, V2, P375, DOI [10.2217/cer.13.43, 10.2217/CER.13.43]
  16. Price SL, 2013, CLIN ORTHOP RELAT R, V471, P3303, DOI 10.1007/s11999-013-3113-5
  17. Rosner Anthony L, 2012, J Bodyw Mov Ther, V16, P42, DOI 10.1016/j.jbmt.2011.05.003
  18. Scutari M, 2010, J STAT SOFTW, V35, P1
  19. Swanson K C, 2000, J Am Acad Orthop Surg, V8, P56
  20. Thein R, 2012, J ARTHROPLASTY, V27, P1658, DOI 10.1016/j.arth.2012.03.036
  21. Wyatt Michael, 2014, World J Orthop, V5, P591, DOI 10.5312/wjo.v5.i5.591
  22. Yli-Kyyny T, 2013, SCAND J SURG, V102, P124, DOI 10.1177/1457496913482249